Navigation Links
CMPI to Host Hill Briefing Tomorrow on Follow-on Biologic Drugs for Media and Congressional Staff With Reps. Eshoo and Rogers
Date:7/14/2009

Event Focused on Ensuring Patient Safety is Top Priority of Follow-on Biologic Legislation Being Debated on Capitol Hill

WASHINGTON, July 14 /PRNewswire-USNewswire/ -- Tomorrow, Wednesday, July 15th, on Capitol Hill, the Center for Medicine in the Public Interest will host a briefing followed by a question-and-answer session for media and Congressional Staff entitled: "A Follow-on Biologics Legislation Update; Congressional Leaders and Medical Experts Discuss Patient Safety." The event will be co-hosted by two high-ranking members of the House Energy and Commerce Committee, Congresswoman Anna Eshoo (D-CA) and Congressman Mike Rogers (R-MI). The Representatives are lead sponsors of bipartisan legislation to modernize the regulatory pathway for Food and Drug Association approval of follow-on biologics.

Representative Eshoo's legislation: H.R. 1548, the Pathway for Biosimilars Act ensures that new standards for testing will make certain that follow-on biologic drugs are both safe and effective. The bill currently has 108 cosponsors and has the broadest bipartisan support of any legislation designed to regulate follow-on biologics.

"CMPI applauds Representatives Eshoo's and Rogers' commitment to ensuring patient safety is the top-priority for follow-on biologics legislation," said Robert Goldberg of CMPI. "The next few weeks are going to be a pivotal time in Congress as health care takes top billing in the House and the Senate. It is critical that advocates for safe and effective follow-on biologics do all they can to support Representative Eshoo's legislation. Representatives Eshoo's and Rogers' dedication to ensuring FDA takes the appropriate steps to ensure the safety of patients could mean the difference between health and illness for millions of Americans."

Also speaking at the event will be former Congressman Mike Ferguson; Dr. Geno Merli, Senior Vice President & Chief Medical Officer, Thomas Jefferson University, and Director, Jefferson Center for Vascular Diseases; and John F. Crowley, President and Chief Executive Officer of Amicus Therapeutics. All three will help highlight the importance of balancing cost reduction and the well-being of patients in the follow-on biologics debate, bringing their unique experiences and perspectives directly to Hill staffers.

    WHO: Representative Anna Eshoo (D-CA), Representative Mike Rogers (R-MI),
    Leading Medical Experts

    WHAT: Briefing for media and Congressional staff

    WHEN: Tomorrow, Wednesday, July 15th, 12-1 p.m.

    WHERE: Cannon Caucus Room, Cannon House Office Building 3rd Floor,
    Washington, D.C.

    WHY: A Follow-On Biologics Legislation Update; Congressional Leaders
    and Medical Experts Discuss Patient Safety

Those interested in attending this event can RSVP via email to Meryl Reichbach at mreichbach@cmpi.org or by calling her at 212-417-9169.

About CMPI

The Center for Medicine in the Public Interest, a non-profit public policy group dedicated to research-based free market reforms for the health care industry.


'/>"/>
SOURCE CMPI
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Americans Wary of Health Legislation: University of Texas/Zogby Poll to be Released on July 15 -- National Press Club to Host "NEWSMAKER" Media Briefing
2. CMPI to Host Hill Briefing on Follow-On Biologic Drugs for Media and Congressional Staff with Reps. Eshoo and Rogers
3. Actuaries Provide Capitol Hill Briefing to Explore Health Care Reform Components
4. AAHSA Expert To Speak To Help Committee Briefing on Health Care Reform and Long-Term Services and Support
5. U.S. Civil Rights Commission to Hold Public Briefing on Health Care Disparities Between Minorities and Non-Minorities, and Business Meeting
6. Advanced Life Sciences Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Restanza(TM) (cethromycin)
7. NPC Newsmaker Program Hosts Briefing on Health Care Reform with Former HHS Secretary Michael Leavitt and Former Senate Majority Leader Tom Daschle
8. Mayo study finds that team preop briefing improves communication, reduces errors
9. Mayo Study Finds That Team Preop Briefing Improves Communication, Reduces Errors
10. Mosaica Partners Briefing Paper Identifies Leading Practices for States and Regions to Leverage ARRA Stimulus Funds for HIE
11. National Press Club to Host NEWSMAKER Media Briefing on Cancer Policy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson ... Recently, he has implemented orthobiologic procedures as a method for treating his patients. ... the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: